Print

SkyePharma Inc. (SKYE) Trims H1 Loss, Meeting FDA on Flutiform  
8/21/2009 6:37:54 AM

Bookmark and Share

Reuters -- British drug delivery specialist SkyePharma trimmed first-half losses on lower revenue and said it remain confident about its key new lung drug Flutiform, despite a delay in the United States.

//-->